Litigation Claims in Vascular Surgery in the United Kingdom's NHS  by Markides, G.A. et al.
JOURNAL OF VASCULAR SURGERY
October 20081066 AbstractsLitigation Claims in Vascular Surgery in the United Kingdom’s NHS
Markides G.A., Subar D., Al-Khaffaf H. Eur J Vasc Endovasc Surg 2008;
36:452-7.
Objectives: To establish the incidence, costs and causes of medical
negligence claims in relation to vascular surgery in the UK’s NHS.
Methods: All claims related to vascular surgery reported to the NHS
Litigation Authority from April 1995 to April 2007 were included in the
study. Data was subsequently reviewed, coded and analysed.
Results: 395 claims were identified (mean: 49/year over last 5 years) of
which 303 had been settled. Damage compensation was given in 160 cases,
with overall litigation costs of approximately 17 million pounds (€21 mil-
lion). The main complaint reasons in successful claims were intra-operative
problems (50%), failure/delay of treatment (14%) and failure/delay of
diagnosis (11%). Varicose vein (VV) surgery was involved in 48% of success-
ful claims, with intra-operative nerve and vessel damage being the major
causes. Peripheral vascular disease (PVD) and abdominal aortic aneurysm
(AAA) disease were the next two types of disease/procedures involved in
successful claims with 21% and 6% respectively.
Conclusions: The number of claims related to vascular surgery has
remained stable over the past 5 years. Improved consenting and higher
surgical skill levels especially in relation to VV surgery and increased diag-
nostic vigilance in PVD, AAA disease and infections are potential areas for
future improvement.
The Role of Superficial Venous Surgery in the Management of Venous
Ulcers: A Systematic Review
Howard D.P.J., Howard A., Kothari A., Wales L., Guest M., Davies A.H.
Eur J Vasc Endovasc Surg 2008;36:458-65.
Background: The complicated natural history of venous ulcers re-
quires the continued development and improvement of treatments to ensure
the most effective management. Compression therapy or surgical correction
of superficial venous incompetence (SVI) are currently the main methods
employed for the treatment for venous ulceration (VU). This review com-
pares and summates the healing and recurrence rates for each treatment
modality used over the last thirty years.
Methods: Sixty-one articles investigating compression and superficial
venous surgical treatments were obtained from a systematic search of elec-
tronic databases (Medline, Embase, The Cochrane Library, and Google
Scholar) and then an expanded reference list review. Patient demographics,
CEAP classification, patterns of venous insufficiency, type of intervention,
length of follow up, healing and recurrence rates for venous ulceration was
assessed. Inadequate data in seven reports led to their exclusion. Recent
randomised controlled trials (RCTs) specifically comparing superficial sur-
gery to compression therapy were reviewed and data from non-randomised
and/or ‘small’ clinical studies prior to 2000 underwent summation analysis.Readers can access EJVES articles at http://intl.ein ulcer recurrence rate with surgery. The effect of deep venous incompe-
tence (DVI) on the ulcer healing is unclear, but sub-group analysis of
long-term data from the ESCHAR trial suggests that although surgery
results in a less impressive reduction in ulcer recurrence in patients withDVI,
these patients appear to still benefit from surgery due to the haemodynamic
and clinical benefits that result. The RCTs also highlight that a significant
proportion of VU patients are unsuitable for surgical treatment.
Summation of data from earlier studies (before 2000), included twen-
ty-one studies employing conservative compression alone resulted in an
overall healing rate of 65% (range 34–95%) and ulcer recurrence of 33%
(range 0–100%). In thirty-one studies investigating superficial venous sur-
gery, the overall rate of ulcer healing was 81% (range 40–100%) with a
post-operative recurrence rate of 15% (range 0–55%). The duration of
follow up care in the surgical studies was approximately twice as long as in
the conservative studies, which would lend to more reliable recurrence data.
Conclusions: Evidence from the current literature, would suggest that
superficial venous surgery is associated with similar rates of ulcer healing to
compression alone, but with less recurrence. The effects of post-operative
compression and DVI on the efficacy of surgery are still unclear.
Randomised Trial of Flush Saphenofemoral Ligation for Primary
Great Saphenous Varicose Veins
Winterborn R.J., Foy C., Heather B.P., Earnshaw J.J. Eur J Vasc Endovasc
Surg 2008;36:477-84.
Objectives: The aim of this study was to assess different techniques of
saphenofemoral ligation in the treatment of primary varicose veins.
Methods: One hundred and eighty-two patients (210 legs) with
primary saphenofemoral junction incompetence were randomised to stan-
dard saphenofemoral ligation (transfixion with an absorbable suture) (SSL)
or flush saphenofemoral ligation (oversewing with 4/0 polypropylene)
(FSL). All legs underwent additional great saphenous vein stripping and
multiple phlebectomies. Patients underwent assessment preoperatively, and
at 6 weeks, 1 year and 2 years postoperatively with clinical examination,
duplex imaging and completion of the Aberdeen Varicose Vein Symptom
Severity Score (AVVSSS).
Results: A total of 148 patients (172 legs) attended follow-up at 2
years postoperatively. Recurrent varicose veins were visible in 30 legs (33 per
cent) in the SSL group and 26 legs (32 per cent) in the FSL group
(P  0.90). Neovascularisation was present in 20 groins (22 per cent) in the
SSL group and 15 groins (19 per cent) in the FSL group (P  0.57). Nine
cases of neovascularisation in the SSL group and five in the FSL group
directly resulted in clinical recurrence (P  0.37).
Conclusions: Flush ligation of the saphenofemoral junction confers no
advantage over standard ligation with respect to clinical recurrence and
neovascularisation.Results: Five RCTs since 2000 demonstrate a similar healing rate of
VU with surgery and conservative compression treatments, but a reduction
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